Working to Eradicate Gynecologic Cancers

Late Breaking Abstract 1
A Randomized Phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group tr

Monday, March 24, 2014: 8:27 AM
Ballroom B/C (Tampa Convention Center)
D. S. McMeekin1, V. L. Filiaci2, C. Aghajanian3, J. Cho4, J. W. Kim5, P. A. DiSilvestro6, D. M. O'Malley7, T. J. Rutherford8, L. Van Le9 and M. E. Randall10
1The University of Oklahoma, Oklahoma City, OK, 2Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 3Memorial Sloan Kettering Cancer Center, New York, NY, 4University Oh Hawaii, hawaii, HI, 5KGOG, Seoul, South Korea, 6Women & Infants Hospital, Brown University, Providence, RI, 7The Ohio State University, Columbus, OH, 8Yale University School of Medicine, New Haven, CT, 9University Of North Carolina, Chapel Hill, Chapel Hill, NC, 10University of Kentucky Medical Center, Lexington, KY
 
See more of: Scientific Plenary V: Late Breaking Abstracts
See more of: Scientific Plenary
<< Previous Presentation | Next Presentation >>